These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017. Bonaldo G; Vaccheri A; D'Annibali O; Motola D Br J Clin Pharmacol; 2019 Mar; 85(3):634-643. PubMed ID: 30569481 [TBL] [Abstract][Full Text] [Related]
5. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308 [TBL] [Abstract][Full Text] [Related]
7. Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015. Myers TR; McNeil MM; Ng CS; Li R; Lewis PW; Cano MV Vaccine; 2017 Mar; 35(14):1758-1763. PubMed ID: 28262331 [TBL] [Abstract][Full Text] [Related]
8. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System. Arana J; Mba-Jonas A; Jankosky C; Lewis P; Moro PL; Shimabukuro TT; Cano M J Adolesc Health; 2017 Nov; 61(5):577-582. PubMed ID: 29061232 [TBL] [Abstract][Full Text] [Related]
9. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455 [TBL] [Abstract][Full Text] [Related]
10. Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013. Miller ER; Moro PL; Cano M; Lewis P; Bryant-Genevier M; Shimabukuro TT Vaccine; 2016 May; 34(25):2841-6. PubMed ID: 27087150 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS). Patricia Wodi A; Marquez P; Mba-Jonas A; Barash F; Nguon K; Moro PL Vaccine; 2023 Feb; 41(9):1616-1622. PubMed ID: 36732165 [TBL] [Abstract][Full Text] [Related]
12. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Shimabukuro TT; Nguyen M; Martin D; DeStefano F Vaccine; 2015 Aug; 33(36):4398-405. PubMed ID: 26209838 [TBL] [Abstract][Full Text] [Related]
13. Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018. Haber P; Moro PL; Ng C; Dores GM; Perez-Vilar S; Marquez PL; Cano M Vaccine; 2020 Feb; 38(6):1476-1480. PubMed ID: 31883809 [TBL] [Abstract][Full Text] [Related]
14. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016. Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003 [TBL] [Abstract][Full Text] [Related]
15. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194 [TBL] [Abstract][Full Text] [Related]
16. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ; MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832 [TBL] [Abstract][Full Text] [Related]
17. Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013. Sukumaran L; McNeil MM; Moro PL; Lewis PW; Winiecki SK; Shimabukuro TT Clin Infect Dis; 2015 May; 60(10):e58-65. PubMed ID: 25637587 [TBL] [Abstract][Full Text] [Related]
18. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546 [TBL] [Abstract][Full Text] [Related]
19. Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017. Suragh TA; Lewis P; Arana J; Mba-Jonas A; Li R; Stewart B; Shimabukuro TT; Cano M Br J Clin Pharmacol; 2018 Dec; 84(12):2928-2932. PubMed ID: 30229993 [TBL] [Abstract][Full Text] [Related]
20. Safety of the 9-Valent Human Papillomavirus Vaccine. Shimabukuro TT; Su JR; Marquez PL; Mba-Jonas A; Arana JE; Cano MV Pediatrics; 2019 Dec; 144(6):. PubMed ID: 31740500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]